---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-025707"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2023-06-01T23:59:59+00:00"
generated_at: "2026-06-14T09:25:14.469850+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Treace Medical to acquire RPM-3D assets for up to $30M; patient-specific guides for foot surgery

## Summary
- $20M upfront cash plus up to $10M milestone payments for RPM-3D's pre-op planning and patient-specific guides.
- FDA-cleared technology to integrate with Lapiplasty and Adductoplasty; commercial launch expected H2 2024.
- Acquisition includes 22 patent applications to strengthen IP portfolio for bunion and foot deformity correction.
- RPM-3D uses CT scan data for 3D pre-operative planning and 3D-printed patient-specific cut guides.
- Transaction follows recent product launches; direct sales force to market new technology.

## SEC filing metadata
- accession: 0000950170-23-025707
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2023-06-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017023025707/0000950170-23-025707-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017023025707/tmci-20230601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-025707
- JSON: https://secwatch.observer/filing/0000950170-23-025707.json
- Plain text: https://secwatch.observer/filing/0000950170-23-025707.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.